Literature DB >> 33511638

Potential COVID-19 Therapeutic Agents and Vaccines: An Evidence-Based Review.

Elnaz Khani1, Sajad Khiali1, Taher Entezari-Maleki1,2.   

Abstract

Since the early days of 2020, the severe acute respiratory syndrome coronavirus 2 pandemic has become a global health concern. Currently, some therapies and vaccines have received US Food and Drug Administration approval or emergency use authorization for the management of coronavirus disease 2019. According to the pathophysiology of the disease, several medications have been evaluated in different clinical conditions of the disease. Evidence-based reviewing and categorizing these medications can guide the clinicians to select the proper medications according to each patient's condition. Therefore, we performed this review to categorize the coronavirus disease 2019 potential therapeutics and vaccines.
© 2021, The American College of Clinical Pharmacology.

Entities:  

Keywords:  COVID-19; IFN-β-1a; SARS-CoV-2; baricitinib; colchicine; convalescent plasma; dexamethasone; methylprednisolone; remdesivir; tocilizumab

Mesh:

Substances:

Year:  2021        PMID: 33511638      PMCID: PMC8014753          DOI: 10.1002/jcph.1822

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  152 in total

Review 1.  The role of antimalarial agents in the treatment of SLE and lupus nephritis.

Authors:  Senq-J Lee; Earl Silverman; Joanne M Bargman
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

2.  Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study.

Authors:  Mona R Loutfy; Lawrence M Blatt; Katharine A Siminovitch; Sarah Ward; Bryan Wolff; Hyoung Lho; Dieu H Pham; Hassan Deif; Elizabeth A LaMere; Margaret Chang; Kevin C Kain; Gabriella A Farcas; Patti Ferguson; Mary Latchford; Gary Levy; James W Dennis; Enoch K Y Lai; Eleanor N Fish
Journal:  JAMA       Date:  2003-12-24       Impact factor: 56.272

3.  Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19).

Authors:  Christian Schoergenhofer; Bernd Jilma; Thomas Stimpfl; Mario Karolyi; Alexander Zoufaly
Journal:  Ann Intern Med       Date:  2020-05-12       Impact factor: 25.391

4.  Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial.

Authors:  Wei Tang; Zhujun Cao; Mingfeng Han; Zhengyan Wang; Junwen Chen; Wenjin Sun; Yaojie Wu; Wei Xiao; Shengyong Liu; Erzhen Chen; Wei Chen; Xiongbiao Wang; Jiuyong Yang; Jun Lin; Qingxia Zhao; Youqin Yan; Zhibin Xie; Dan Li; Yaofeng Yang; Leshan Liu; Jieming Qu; Guang Ning; Guochao Shi; Qing Xie
Journal:  BMJ       Date:  2020-05-14

5.  In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19.

Authors:  Xiao-Jing Zhang; Juan-Juan Qin; Xu Cheng; Lijun Shen; Yan-Ci Zhao; Yufeng Yuan; Fang Lei; Ming-Ming Chen; Huilin Yang; Liangjie Bai; Xiaohui Song; Lijin Lin; Meng Xia; Feng Zhou; Jianghua Zhou; Zhi-Gang She; Lihua Zhu; Xinliang Ma; Qingbo Xu; Ping Ye; Guohua Chen; Liming Liu; Weiming Mao; Youqin Yan; Bing Xiao; Zhigang Lu; Gang Peng; Mingyu Liu; Jun Yang; Luyu Yang; Changjiang Zhang; Haofeng Lu; Xigang Xia; Daihong Wang; Xiaofeng Liao; Xiang Wei; Bing-Hong Zhang; Xin Zhang; Juan Yang; Guang-Nian Zhao; Peng Zhang; Peter P Liu; Rohit Loomba; Yan-Xiao Ji; Jiahong Xia; Yibin Wang; Jingjing Cai; Jiao Guo; Hongliang Li
Journal:  Cell Metab       Date:  2020-06-24       Impact factor: 27.287

Review 6.  Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases.

Authors:  Md Abdul Alim Al-Bari
Journal:  J Antimicrob Chemother       Date:  2015-02-17       Impact factor: 5.790

7.  Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.

Authors:  Hongchao Pan; Richard Peto; Ana-Maria Henao-Restrepo; Marie-Pierre Preziosi; Vasee Sathiyamoorthy; Quarraisha Abdool Karim; Marissa M Alejandria; César Hernández García; Marie-Paule Kieny; Reza Malekzadeh; Srinivas Murthy; K Srinath Reddy; Mirta Roses Periago; Pierre Abi Hanna; Florence Ader; Abdullah M Al-Bader; Almonther Alhasawi; Emma Allum; Athari Alotaibi; Carlos A Alvarez-Moreno; Sheila Appadoo; Abdullah Asiri; Pål Aukrust; Andreas Barratt-Due; Samir Bellani; Mattia Branca; Heike B C Cappel-Porter; Nery Cerrato; Ting S Chow; Najada Como; Joe Eustace; Patricia J García; Sheela Godbole; Eduardo Gotuzzo; Laimonas Griskevicius; Rasha Hamra; Mariam Hassan; Mohamed Hassany; David Hutton; Irmansyah Irmansyah; Ligita Jancoriene; Jana Kirwan; Suresh Kumar; Peter Lennon; Gustavo Lopardo; Patrick Lydon; Nicola Magrini; Teresa Maguire; Suzana Manevska; Oriol Manuel; Sibylle McGinty; Marco T Medina; María L Mesa Rubio; Maria C Miranda-Montoya; Jeremy Nel; Estevao P Nunes; Markus Perola; Antonio Portolés; Menaldi R Rasmin; Aun Raza; Helen Rees; Paula P S Reges; Chris A Rogers; Kolawole Salami; Marina I Salvadori; Narvina Sinani; Jonathan A C Sterne; Milena Stevanovikj; Evelina Tacconelli; Kari A O Tikkinen; Sven Trelle; Hala Zaid; John-Arne Røttingen; Soumya Swaminathan
Journal:  N Engl J Med       Date:  2020-12-02       Impact factor: 91.245

8.  Lopinavir/ritonavir in the treatment of HIV-1 infection: a review.

Authors:  Ashish Chandwani; Jonathan Shuter
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

9.  Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors.

Authors:  Melissa Bersanelli
Journal:  Immunotherapy       Date:  2020-03-26       Impact factor: 4.196

10.  Dexamethasone in Hospitalized Patients with Covid-19.

Authors:  Peter Horby; Wei Shen Lim; Jonathan R Emberson; Marion Mafham; Jennifer L Bell; Louise Linsell; Natalie Staplin; Christopher Brightling; Andrew Ustianowski; Einas Elmahi; Benjamin Prudon; Christopher Green; Timothy Felton; David Chadwick; Kanchan Rege; Christopher Fegan; Lucy C Chappell; Saul N Faust; Thomas Jaki; Katie Jeffery; Alan Montgomery; Kathryn Rowan; Edmund Juszczak; J Kenneth Baillie; Richard Haynes; Martin J Landray
Journal:  N Engl J Med       Date:  2020-07-17       Impact factor: 91.245

View more
  6 in total

1.  Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine.

Authors:  Hua Zhong; Shuai Liu; Fang Cao; Yi Zhao; Jianguo Zhou; Feng Tang; Zhaohua Peng; Yangsheng Li; Shen Xu; Chunlin Wang; Guohua Yang; Zhi-Qiang Li
Journal:  Front Immunol       Date:  2021-08-27       Impact factor: 7.561

2.  Factors associated with admission to the intensive care unit and mortality in patients with COVID-19, Colombia.

Authors:  Jorge Enrique Machado-Alba; Luis Fernando Valladales-Restrepo; Manuel Enrique Machado-Duque; Andrés Gaviria-Mendoza; Nicolás Sánchez-Ramírez; Andrés Felipe Usma-Valencia; Esteban Rodríguez-Martínez; Eliana Rengifo-Franco; Víctor Hugo Forero-Supelano; Diego Mauricio Gómez-Ramirez; Alejandra Sabogal-Ortiz
Journal:  PLoS One       Date:  2021-11-19       Impact factor: 3.240

3.  Liposomal Formulation of a PLA2-Sensitive Phospholipid-Allocolchicinoid Conjugate: Stability and Activity Studies In Vitro.

Authors:  Maria K Kobanenko; Daria S Tretiakova; Ekaterina S Shchegravina; Nadezhda V Antipova; Ivan A Boldyrev; Alexey Yu Fedorov; Elena L Vodovozova; Natalia R Onishchenko
Journal:  Int J Mol Sci       Date:  2022-01-18       Impact factor: 5.923

Review 4.  Comprehensive review on molnupiravir in COVID-19: a novel promising antiviral to combat the pandemic.

Authors:  Sajad Khiali; Elnaz Khani; Samineh B Rouy; Taher Entezari-Maleki
Journal:  Future Microbiol       Date:  2022-02-24       Impact factor: 3.165

Review 5.  A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment.

Authors:  Yasser Mohamed; Yousra A El-Maradny; Ahmed K Saleh; AbdElAziz A Nayl; Hamada El-Gendi; Esmail M El-Fakharany
Journal:  Biomed Pharmacother       Date:  2022-08-02       Impact factor: 7.419

6.  COVID‑19 vaccination and IgG and IgA antibody dynamics in healthcare workers.

Authors:  Sabina Zurac; Luciana Nichita; Bogdan Mateescu; Cristian Mogodici; Alexandra Bastian; Cristiana Popp; Mirela Cioplea; Claudiu Socoliu; Carolina Constantin; Monica Neagu
Journal:  Mol Med Rep       Date:  2021-06-16       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.